Enanta Pharmaceuticals Inc (ENTA)

[ASPRV]

I see. You think it is still a big opportunity for ENTA, don't you? I understand it. Compared to its Market Cap. it is huge, isn't it?

What I meant about transition is PFE says one of the reasons for poor revenue on Paxlovid is they are changing their method of sales to commercial markets rather than to government deals. That's what I understood from their recent conference call. I was asking you guys' opinion on it. Whether it would be better for PFE's Paxlovid sales or not.